Efficiency and cytotoxicity analysis of cationic lipids-mediated gene transfection into AGS gastric cancer cells

Abstract In this effort, we provided comparative study on optimization of transfection conditions for AGS human gastric cancer cell line using two commercial non-liposomal cationic lipids. Using reporter vector pEGFP-N1, transfection efficiency of Attractene™ and X-tremeGENE HP™ transfection reagents in terms of cell densities and DNA/reagent ratios was determined in AGS cells by flow cytometry and fluorescence microscopy. In addition, influence of transfection reagents on direct cytotoxicity and cell viability was respectively, measured using lactate dehydrogenase (LDH) leakage and MTT assays. Provided that the transfection rate of 29% and the mean fluorescence intensity of 437.5, the DNA/reagent ratio of 0.4/1.5 was selected as the optimal condition using Attractene™, whereas the optimum condition using X-tremeGENE HP™ was obtained by the ratio of 1/2 with a higher transfection rate of 36.9% and an MFI of 833. Very low direct cytotoxicity (<5% and 6–9% using Attractene™ and X-tremeGENE HP™, respectively) and high cell viability (74.5–95.5% versus 68–75%) showed the biodegradable attribute for both transfection reagents. Altogether, X-tremeGENE HP™ exhibited superiority over Attractene™ as a transfection reagent for AGS cells. In the present research, we have established the optimized protocols for efficient transfection of AGS cells with potential applications in gene function and expression studies as well as gene therapy.

[1]  P. Trivedi,et al.  Advances in siRNA delivery in cancer therapy , 2018, Artificial cells, nanomedicine, and biotechnology.

[2]  Abolfazl Akbarzadeh,et al.  Recent advances on liposomal nanoparticles: synthesis, characterization and biomedical applications , 2017, Artificial cells, nanomedicine, and biotechnology.

[3]  R. Chandra,et al.  Effect of size on biological properties of nanoparticles employed in gene delivery , 2016, Artificial cells, nanomedicine, and biotechnology.

[4]  Christopher M. Walthers,et al.  Gene Delivery Strategies to Promote Spinal Cord Repair , 2015, Biomarker insights.

[5]  E Gratton,et al.  Mechanistic evaluation of the transfection barriers involved in lipid-mediated gene delivery: interplay between nanostructure and composition. , 2014, Biochimica et biophysica acta.

[6]  Qing Zhou,et al.  Optimization of transfection parameters for ultrasound/SonoVue microbubble-mediated hAng-1 gene delivery in vitro. , 2012, Molecular medicine reports.

[7]  H. Uludaǧ,et al.  Cellular uptake pathways of lipid-modified cationic polymers in gene delivery to primary cells. , 2012, Biomaterials.

[8]  R. Verrall,et al.  Evaluation of cellular uptake and intracellular trafficking as determining factors of gene expression for amino acid-substituted gemini surfactant-based DNA nanoparticles , 2012, Journal of Nanobiotechnology.

[9]  R. Vandenbroucke,et al.  Title: the Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimisation and Pitfalls the Use of Inhibitors to Study Endocytic Pathways of Gene Carriers: Optimisation and Pitfalls Dries Vercauteren , 2022 .

[10]  D. Burgess,et al.  Optimization and characterization of anionic lipoplexes for gene delivery. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Y. Omidi,et al.  Microarray Analysis of the Toxicogenomics and the Genotoxic Potential of a Cationic Lipid-Based Gene Delivery Nanosystem in Human Alveolar Epithelial A549 Cells , 2008, Toxicology mechanisms and methods.

[12]  A. Chaudhuri,et al.  Cationic liposomes as non‐viral carriers of gene medicines: Resolved issues, open questions, and future promises , 2007, Medicinal research reviews.

[13]  I. Zuhorn,et al.  Gene delivery by cationic lipids: in and out of an endosome. , 2007, Biochemical Society transactions.

[14]  John A Timbrell,et al.  In vitro cytotoxicity assays: comparison of LDH, neutral red, MTT and protein assay in hepatoma cell lines following exposure to cadmium chloride. , 2006, Toxicology letters.

[15]  M. Kirkham,et al.  Erratum to “Clathrin-independent endocytosis: New insights into caveolae and non-caveolar lipid raft carriers” [Biochim. Biophys. Acta 1744 (2005) 273–286] , 2005 .

[16]  Y. Omidi,et al.  Toxicogenomics of cationic lipid-based vectors for gene therapy: impact of microarray technology. , 2005, Current drug delivery.

[17]  A. Zimmer,et al.  Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[18]  J. Gorvel,et al.  Macropinocytosis of polyplexes and recycling of plasmid via the clathrin-dependent pathway impair the transfection efficiency of human hepatocarcinoma cells. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[19]  Y. Baba,et al.  Cationic liposome-mediated gene delivery: biophysical study and mechanism of internalization. , 2003, Archives of biochemistry and biophysics.

[20]  S. Simões,et al.  Evaluation of lipid-based reagents to mediate intracellular gene delivery. , 2002, Biochimica et biophysica acta.

[21]  J. Pelisek,et al.  Optimization of nonviral transfection: variables influencing liposome-mediated gene transfer in proliferating vs. quiescent cells in culture and in vivo using a porcine restenosis model , 2002, Journal of Molecular Medicine.

[22]  S. Simões,et al.  Cationic liposomes as gene transfer vectors: barriers to successful application in gene therapy. , 1999, Current opinion in molecular therapeutics.

[23]  E. Hersh,et al.  Cationic lipid-mediated gene transfer: current concepts. , 1999, Current opinion in molecular therapeutics.

[24]  T. Yasuda,et al.  Gene transfection by cationic liposomes: comparison of the transfection efficiency of liposomes prepared from various positively charged lipids. , 1997, Acta medica Okayama.

[25]  M. Keogh,et al.  High efficiency reporter gene transfection of vascular tissue in vitro and in vivo using a cationic lipid–DNA complex , 1997, Gene Therapy.

[26]  S W Hui,et al.  The role of helper lipids in cationic liposome-mediated gene transfer. , 1996, Biophysical journal.

[27]  R. Malone,et al.  Structural and functional analysis of cationic transfection lipids: the hydrophobic domain. , 1996, Gene therapy.

[28]  Jonathan M. Harris.  CONFERENCE Gene delivery and therapy strategies , 1993, The Lancet.

[29]  R. Leventis,et al.  Interactions of mammalian cells with lipid dispersions containing novel metabolizable cationic amphiphiles. , 1990, Biochimica et biophysica acta.

[30]  R. Koynova,et al.  Cationic lipids: molecular structure/ transfection activity relationships and interactions with biomembranes. , 2010, Topics in current chemistry.

[31]  M. Soleimani,et al.  Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. , 2008, Cytotherapy.

[32]  Robert G Parton,et al.  Clathrin-independent endocytosis: new insights into caveolae and non-caveolar lipid raft carriers. , 2005, Biochimica et biophysica acta.

[33]  F. Gaunitz,et al.  Long-term expression of foreign genes in normal human epidermal keratinocytes after transfection with lipid/DNA complexes , 2001, Histochemistry and Cell Biology.

[34]  K. Iatrou,et al.  Use of flow cytometry to rapidly optimize the transfection of animal cells. , 2000, BioTechniques.

[35]  P. Mougin,et al.  Gene transfer into subcultured endometrial cells using lipofection. , 1996, BioTechniques.

[36]  J. Harris.  Gene delivery and therapy strategies. , 1993, Lancet.

[37]  P. Felgner,et al.  Cationic liposome mediated transfection. , 1989, Proceedings of the Western Pharmacology Society.